These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Panel of candidate biomarkers for renal cell carcinoma. Kim DS; Choi YP; Kang S; Gao MQ; Kim B; Park HR; Choi YD; Lim JB; Na HJ; Kim HK; Nam YP; Moon MH; Yun HR; Lee DH; Park WM; Cho NH J Proteome Res; 2010 Jul; 9(7):3710-9. PubMed ID: 20455597 [TBL] [Abstract][Full Text] [Related]
3. The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update. Campagna R; Pozzi V; Spinelli G; Sartini D; Milanese G; Galosi AB; Emanuelli M Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439880 [TBL] [Abstract][Full Text] [Related]
4. Nicotinamide N-methyltransferase protein expression in renal cell cancer. Zhang J; Xie XY; Yang SW; Wang J; He C J Zhejiang Univ Sci B; 2010 Feb; 11(2):136-43. PubMed ID: 20104648 [TBL] [Abstract][Full Text] [Related]
5. Nicotinamide N-methyltransferase decreases 5-fluorouracil sensitivity in human esophageal squamous cell carcinoma through metabolic reprogramming and promoting the Warburg effect. Cui Y; Yang D; Wang W; Zhang L; Liu H; Ma S; Guo W; Yao M; Zhang K; Li W; Zhang Y; Guan F Mol Carcinog; 2020 Aug; 59(8):940-954. PubMed ID: 32367570 [TBL] [Abstract][Full Text] [Related]
6. Nicotinamide N-methyltransferase: At the crossroads between cellular metabolism and epigenetic regulation. Roberti A; Fernández AF; Fraga MF Mol Metab; 2021 Mar; 45():101165. PubMed ID: 33453420 [TBL] [Abstract][Full Text] [Related]
7. Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization. Wang Y; Zeng J; Wu W; Xie S; Yu H; Li G; Zhu T; Li F; Lu J; Wang GY; Xie X; Zhang J Breast Cancer Res; 2019 May; 21(1):64. PubMed ID: 31101119 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of nicotinamide N-methyltransferase in HSC-2 OSCC cell line: effect on apoptosis and cell proliferation. Seta R; Mascitti M; Campagna R; Sartini D; Fumarola S; Santarelli A; Giuliani M; Cecati M; Muzio LL; Emanuelli M Clin Oral Investig; 2019 Feb; 23(2):829-838. PubMed ID: 29882109 [TBL] [Abstract][Full Text] [Related]
9. Involvement of transforming growth factor beta 1 in the transcriptional regulation of nicotinamide N-methyltransferase in clear cell renal cell carcinoma. Campagna R; Cecati M; Pozzi V; Fumarola S; Pompei V; Milanese G; Galosi AB; Sartini D; Emanuelli M Cell Mol Biol (Noisy-le-grand); 2018 May; 64(7):51-55. PubMed ID: 29974846 [TBL] [Abstract][Full Text] [Related]
10. Nicotinamide-N-methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma. Reustle A; Menig LS; Leuthold P; Hofmann U; Stühler V; Schmees C; Becker M; Haag M; Klumpp V; Winter S; Büttner FA; Rausch S; Hennenlotter J; Fend F; Scharpf M; Stenzl A; Bedke J; Schwab M; Schaeffeler E Clin Transl Med; 2022 Jun; 12(6):e883. PubMed ID: 35678045 [TBL] [Abstract][Full Text] [Related]
11. Qian Yang Yu Yin Granule protects against hypertension-induced renal injury by epigenetic mechanism linked to Nicotinamide N-Methyltransferase (NNMT) expression. Zhang SF; Mao XJ; Jiang WM; Fang ZY J Ethnopharmacol; 2020 Jun; 255():112738. PubMed ID: 32147479 [TBL] [Abstract][Full Text] [Related]
12. Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review. Togni L; Mascitti M; Sartini D; Campagna R; Pozzi V; Salvolini E; Offidani A; Santarelli A; Emanuelli M Biomolecules; 2021 Oct; 11(11):. PubMed ID: 34827592 [TBL] [Abstract][Full Text] [Related]
13. Composite three-marker assay for early detection of kidney cancer. Su Kim D; Choi YD; Moon M; Kang S; Lim JB; Kim KM; Park KM; Cho NH Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):390-8. PubMed ID: 23479363 [TBL] [Abstract][Full Text] [Related]
14. Nicotinamide N-methyltransferase induces cellular invasion through activating matrix metalloproteinase-2 expression in clear cell renal cell carcinoma cells. Tang SW; Yang TC; Lin WC; Chang WH; Wang CC; Lai MK; Lin JY Carcinogenesis; 2011 Feb; 32(2):138-45. PubMed ID: 21045016 [TBL] [Abstract][Full Text] [Related]
18. The significance of NAD + metabolites and nicotinamide N-methyltransferase in chronic kidney disease. Takahashi R; Kanda T; Komatsu M; Itoh T; Minakuchi H; Urai H; Kuroita T; Shigaki S; Tsukamoto T; Higuchi N; Ikeda M; Yamanaka R; Yoshimura N; Ono T; Yukioka H; Hasegawa K; Tokuyama H; Wakino S; Itoh H Sci Rep; 2022 Apr; 12(1):6398. PubMed ID: 35430611 [TBL] [Abstract][Full Text] [Related]
19. Complex roles of nicotinamide N-methyltransferase in cancer progression. Wang W; Yang C; Wang T; Deng H Cell Death Dis; 2022 Mar; 13(3):267. PubMed ID: 35338115 [TBL] [Abstract][Full Text] [Related]
20. Nicotinamide N-methyltransferase is related to MELF pattern invasion in endometrioid carcinoma. Tahara S; Nojima S; Ohshima K; Hori Y; Sato K; Kurashige M; Matsui T; Okuzaki D; Morii E Cancer Med; 2021 Dec; 10(23):8630-8640. PubMed ID: 34655178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]